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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER791Silent Brain Injury After Cardiac SurgeryXiumei Sun, Joseph Lindsay, Lee H. Monsein, Peter C. Hill, Paul J. Corso
The appearance of cognitive dysfunction after cardiac surgery in the absence of focal
neurologic signs is a poorly understood but potentially devastating complication. Confirmation
of the occurrence of peri-operative “silent brain injury” has been developed through advances
in magnetic resonance imaging (MRI) techniques, which detect new brain lesions in 25% to
50% of patients after either coronary artery bypass graft or valve surgery. However,
quantifying new cognitive dysfunction is difficult because of the need for extensive pre- and
post-operative testing, which is subject to ascertainment bias. Sun and colleagues argue that
the post-operative appearance of MRI lesions would serve as a more objective marker of brain
injury in research efforts.CLINICAL RESEARCH CORONARY REVASCULARIZATION798Risk of Stroke Lower With PCI Than CABGTullio Palmerini, Giuseppe Biondi-Zoccai, Letizia Bacchi Reggiani, Diego Sangiorgi, Laura Alessi,
Stefano De Servi, Angelo Branzi, Gregg W. Stone
Palmerini and colleagues performed a meta-analysis of 19 trials in which 10,944 patients were
randomized to coronary artery bypass graft (CABG) surgery or percutaneous coronary
intervention (PCI) to determine whether there are differences in the rate of peri-procedural
stroke. The 30-day rate of stroke was 1.20% after CABG compared to 0.34% after PCI
(odds ratio [OR]: 2.94). Similar results were observed after a median follow-up of 1 year and
were not affected by the extent of coronary artery disease (single-vessel vs. multivessel vs. left
main). This meta-analysis confirms that patients treated with CABG have a significantly
higher risk of stroke than those treated with PCI, with an excess of 7 strokes for every 1,000
patients treated.(continued on page A-22)
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806re-Hospital ECG May Improve Scene Time and Transport Time
for STEMI PatientsMitul Patel, James V. Dunford, Steve Aguilar, Edward Castillo, Ekta Patel, Roger Fisher,
Ginger Ochs, Ehtisham Mahmud
Pre-hospital electrocardiography (PH ECG) decreases door-to balloon (D2B) time for ST-
segment elevation myocardial infarction (STEMI) patients; however, obtaining a PH ECG
may prolong the time the paramedics are at the scene. Patel and colleagues investigated the
impact of obtaining a PH ECG on both scene and transport times for patients with chest
pain suspected of cardiac origin. Implementation of PH ECG resulted in minimal increases
in median scene time (19:10 min:s vs. 19:28 min:s) and transport time (13:16 min:s vs. 13:28
min:s). However, compared to chest pain patients, STEMI patients had shorter scene time
(17:51 min:s vs. 19:31 min:s) and transport time (12:34 min:s vs. 13:31 min:s). Obtaining a
PH ECG for patients with chest pain minimally prolongs scene and transport times, but may
expedite transit times for those identified as a STEMI.Editorial Comment: Umesh N. Khot, p. 812ACUTE CORONARY SYNDROMES814Risk Associated With Family History of Early Cardiac DeathMattis Flyvholm Ranthe, Lisbeth Carstensen, Nina Øyen, Jacob Tfelt-Hansen, Michael Christiansen,
William J. McKenna, Jan Wohlfahrt, Mads Melbye, Heather A. Boyd
Ranthe and colleagues used the integrated databases of the Danish Health Care System to study
the risks associated with a family history of premature death (60 years of age), cardiovascular
death in particular. The incident rate ratios (IRRs) for any early (50 years of age) cardiovascular
disease, ischemic heart disease, or ventricular arrhythmia, given a history of premature cardiovascu-
lar death in 1 first-degree relative were approximately 2.00. If there were 2 cardiovascular deaths
in a family, the rates were doubled again. Family history of premature cardiovascular death was
consistently and significantly associated with risk of early cardiovascular disease.HEART FAILURE: VIEWPOINT822Standard Reporting Criteria for Acute Heart Failure in the Emergency RoomAlan B. Storrow, Christopher J. Lindsell, Sean P. Collins, Deborah B. Diercks, Gerasimos S. Filippatos,
Brian C. Hiestand, Judd E. Hollander, J. Douglas Kirk, Phillip D. Levy, Chadwick D. Miller,
Allen J. Naftilan, Richard M. Nowak, Peter S. Pang, W. Frank Peacock, Mihai Gheorghiade,
John G. F. Cleland
While acute heart failure syndromes are commonly defined as a change in chronic heart
failure signs and symptoms requiring urgent therapy, the presentation, development, and
response to treatment is highly dependent on individual patient characteristics. This
heterogeneity has led to challenges in interpreting different study methods, including
eligibility requirements and outcome measures. To improve interpretation of results, and
translate such information to better patient care, the Standardized Reporting Criteria Work-
ng Group and the Emergency Management and Research Group in Acute Heart Failure present
tandardized reporting criteria to improve interpretability of research in this challenging cohort.
(continued on page A-23)
AUGUST 28, 2012 (continued) A-23(
c
p
T
C
h
J
pHEART VALVE DISEASE833Beta-Blockers May Be Beneficial for Patients With Chronic Mitral RegurgitationMustafa I. Ahmed, Inmaculada Aban, Steven G. Lloyd, Himanshu Gupta, George Howard,
Seidu Inusah, Kalyani Peri, Jessica Robinson, Patty Smith, David C. McGiffin, Chun G. Schiros,
Thomas Denney, Jr, Louis J. Dell’Italia
In the canine model of isolated mitral regurgitation (MR), chronic 1-adrenergic receptor
AR) blockade improves cardiomyocyte and left ventricular (LV) function. Ahmed and
olleagues randomized 38 asymptomatic subjects with moderate to severe MR to either
lacebo or 1-AR blockade. Magnetic resonance imaging with tissue tagging and
3-dimensional analysis was performed at baseline and at 6-month intervals for 2 years.
Significant treatment effects were found on LV ejection fraction and LV early diastolic filling
rate, which both worsened in untreated patients but not in those assigned to 1 blockade.
his small trial suggests the need for a larger trial of 1-AR blockade for patients with
isolated MR powered to detect differences in clinical endpoints.Editorial Comment: Blase A. Carabello, p. 839HEART RHYTHM DISORDERS
841ommon Variants in the NOS1AP Gene Associated
With Drug-Induced QT Prolongation and Ventricular ArrhythmiaYalda Jamshidi, Ilja M. Nolte, Chrysoula Dalageorgou, Dongling Zheng, Toby Johnson, Rachel Bastiaenen,
Suzanne Ruddy, Daniel Talbott, Kris J. Norris, Harold Snieder, Alfred L. George, Vanessa Marshall,
Saad Shakir, Prince Joseph Kannankeril, Patricia B. Munroe, A. John Camm, Steve Jeffery, Dan M. Roden,
Elijah R. Behr
Recent studies have demonstrated a role for NOS1AP gene variants in modulating QT interval in
ealthy subjects and the risk of arrhythmias in subjects with long QT syndrome (LQTS).
amshidi and colleagues carried out an association study using 167 single nucleotide
olymorphism spanning the NOS1AP gene in 58 Caucasian patients experiencing drug-
induced LQTS (dLQTS) and 87 Caucasian controls. Association analysis identified 1
polymorphism significantly associated with dLQTS (rs10800397), particularly in subjects
who experienced dLQTS with amiodarone. These findings were then replicated in an
independent cohort. These results provide the first demonstration that common variations
in the NOS1AP gene are associated with a significant increase in the risk of dLQTS.(continued on page A-24)
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851besity May Predispose to AF by Increasing Left Atrial Pressure
and Shortening the ERP of Atrial TissueThomas M. Munger, Ying-Xue Dong, Mitsuru Masaki, Jae K. Oh, Sunil V. Mankad, Barry A. Borlaug,
Samuel J. Asirvatham, Win-Kuang Shen, Hon-Chi Lee, Suzette J. Bielinski, David O. Hodge,
Regina M. Herges, Traci L. Buescher, Jia-Hui Wu, Changsheng Ma, Yanhua Zhang, Peng-Sheng Chen,
Douglas L. Packer, Yong-Mei Cha
Munger and colleagues have noted that obesity is associated with an increased risk of atrial
fibrillation (AF) and sought to characterize the left atrial (LA) and pulmonary vein (PV)
electrophysiologic and hemodynamic features in obese patients with AF. Obese patients had a
shorter effective refractory period (ERP) in the LA and PV than normal body mass index
patients. Obese patients also had higher mean LA pressure and LA volume index. These are
potential factors facilitating and perpetuating AF in obese patients.ANTITHROMBOTIC THERAPY
861omparison of 3 Different Bleeding Risk
Prediction Scores Finds HAS-BLED SuperiorStavros Apostolakis, Deirdre A. Lane, Yutao Guo, Harry Buller, Gregory Y. H. Lip
Three bleeding risk prediction schemes have been derived and validated in atrial fibrillation
(AF) populations: HEMORR2HAGES, ATRIA, and HAS-BLED. Apostolakis and
olleagues used data from a large trial to determine the relative predictive value of these
leeding scores for patients treated with adjusted-dose oral vitamin K antagonist (VKA)
herapy. The principal safety outcome was ‘any clinically relevant bleeding,’ which was a
omposite of ‘major bleeding’ plus ‘clinically relevant non-major bleeding.’ The HAS-BLED
core performed best in predicting ‘any clinically relevant bleeding,’ reflected both in net
eclassification improvement and receiver-operating characteristic analyses. Given its simplicity
nd superior performance, the HAS-BLED score appears useful for the estimation of VKA-
elated bleeding risk in clinical practice.
